The clinicopathological and prognostic value of Nanog in human gastrointestinal luminal cancer: A meta-analysis
- 28 March 2018
- journal article
- review article
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 53, 193-200
Abstract
Background: Recent studies have demonstrated that the over-expression of Nanog contributes to the progression of various malignant tumors. However, the clinicopathological and prognostic role of Nanog in gastrointestinal luminal cancer remains controversial. Therefore, we conducted a meta-analysis to assess the role of Nanog in gastrointestinal luminal cancer. Methods: An electronic search for relevant literature was performed in PubMed, Cochrane Library, Web of Science, and EMBASE databases. The relationships between Nanog expression and clinicopathological features and survival outcomes were analyzed. Pooled odds ratios (ORs) and hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated by STATA14.2 and RevMan 5.3 software. Results: A total of 9 studies with 1526 patients were included in this meta-analysis. The positive expression of Nanog was related to gender, depth of infiltration, differentiation, and TNM stage; however, it was not associated with age, tumor size, or lymph node metastasis. Moreover, positive Nanog expression was correlated with a poor overall survival (OS) and poor disease-free survival (DFS) in gastrointestinal luminal cancer. Conclusion: The pooled results suggested that Nanog expression was associated with gender, depth of infiltration, differentiation, and TNM stage, and Nanog may be a potential biomarker to predict the prognosis of gastrointestinal luminal cancer.Keywords
This publication has 32 references indexed in Scilit:
- Pin1-Nanog expression in human glioma is correlated with advanced tumor progressionOncology Reports, 2013
- NANOG modulates stemness in human colorectal cancerOncogene, 2012
- Role of the Stemness Factors Sox2, Oct3/4, and Nanog in Gastric CarcinomaJournal of Surgical Research, 2012
- Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinomaHepatology, 2012
- Salinomycin can effectively kill ALDHhigh stem-like cells on gastric cancerBiomedicine & Pharmacotherapy, 2011
- Cells of origin in cancerNature, 2011
- Understanding the cancer stem cellBritish Journal of Cancer, 2010
- Over-expression of Nanog predicts tumor progression and poor prognosis in colorectal cancerCancer Biology & Therapy, 2010
- New therapies for hepatocellular carcinomaOncogene, 2006
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2003